Edgen Stock·Sep 20 2025, 07:59戻る
戻る
Innate Pharma Shares Decline Amid Strategic Restructuring and H1 2025 Financial Report
Edgen Stock·Sep 20 2025, 07:59
[1] Innate Pharma SA (IPHA) (H1 2025) Earnings Call Highlights: Strategic Focus and Financial Resilience Amidst Challenges (https://finance.yahoo.com/news/innate-pharma- ...)[2] Innate Pharma H1 Net Loss Shrinks, Plans 30% Workforce Cut, Stock Drops | Nasdaq (https://vertexaisearch.cloud.google.com/groun ...)[3] Innate Pharma H1 2025 slides: strategic refocus on key assets extends cash runway (https://vertexaisearch.cloud.google.com/groun ...)